International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e360-e364 , November 2009

Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting

  • N. Kumarasamy

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 44 22542929; fax: +91 44 22542939.
    • ,
  • Kartik K. Venkatesh

      Affiliations

    • Brown University Medical School and the Miriam Hospital, Providence, Rhode Island, USA
    • ,
  • Bella Devaleenol

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Suneeta Saghayam

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Deepak Manohar

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • S. Poongulali

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Tokugha Yepthomi

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Pradeep Ambrose

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Suniti Solomon

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • ,
  • Kenneth H. Mayer

      Affiliations

    • Brown University Medical School and the Miriam Hospital, Providence, Rhode Island, USA

Received 31 May 2008 ,Revised 24 October 2008 ,Accepted 17 November 2008.

  • Image Result

    Flow chart of study participants.

    Flow chart of study participants.

  • Image Result

    CD4 count and hemoglobin comparison between patients who substituted with AZT at <6 months after initiating d4T vs. patients who substituted at 6–12 months. *Signifies a statistically significant diff

    CD4 count and hemoglobin comparison between patients who substituted with AZT at <6 months after initiating d4T vs. patients who substituted at 6–12 months. *Signifies a statistically significant difference (p<0.05).

PII: S1201-9712(09)00072-1

doi: 10.1016/j.ijid.2008.11.030

International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e360-e364 , November 2009

Article Tools

* Image Usage & Resolution